Elanco Animal Health vs Organon &
Organon & is the larger business, with $6.22bn of revenue in fiscal 2025 against $4.71bn for Elanco Animal Health (1.3 times as much). Elanco Animal Health grew faster (6.2% against -2.9%). Organon & kept more of each dollar of sales as profit: a net margin of 3.0% against -4.9%. Elanco Animal Health carries less debt relative to equity (61.4% against 1149.5%).
| Latest fiscal year | Elanco Animal HealthELAN, 2025 | Organon &OGN, 2025 |
|---|---|---|
| Revenue | $4.71bn | $6.22bn |
| Revenue growth | 6.2% | -2.9% |
| Net income | −$232m | $187m |
| Operating margin | — | — |
| Net margin | -4.9% | 3.0% |
| Return on equity | -3.7% | 30.6% |
| Free cash flow | $284m | $538m |
| Cash | $545m | $574m |
| Total debt | $4.02bn | $8.64bn |
| Debt to equity | 61.4% | 1149.5% |
| Dividend per share | — | $0.34 |
| Dividend yield | — | 0.6% |
| Share buybacks | — | — |
| Employees | 9,000 | 10,000 |
| Market value | $12.23bn | $3.64bn |
| Price vs our value range | Above our value range | Below our value range |
| Moat score | 42 (Weak) | 56 (Moderate) |
| Insider trades, 12 months | 11 buys, 1 sales | 2 buys, 2 sales |